Effect of Dopaminergic Therapy on Impulse Control Disorders in Patients With a Prolactinoma

Effect of Dopaminergic Therapy on Impulse Control Disorders in Patients With a Prolactinoma
Cogn Behav Neurol. 2022 Sep 26. doi: 10.1097/WNN.0000000000000320. Online ahead of print.ABSTRACTBACKGROUND: Studies have reported an increase in the incidence of impulse control disorders (ICDs) in patient groups treated with dopamine agonists (DAAs), especially in Parkinson disease (PD). However, very few studies have reported on ICDs in individuals with a prolactinoma who were treated with DAAs.OBJECTIVE: To see whether a ... read more
Source: PubMedPublished on 2022-09-23By Esin Ozdeniz Varan